Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Canada’s pharmaceutical industry is undergoing a major transition towards personalized medicine, which customizes therapies ...

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

We are on the cusp of reimagining healthcare, with AI, wearables, multimodal data, AR/VR, and other innovations rapidly accelerating the field. Over the last few years, the medical community has ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

University of Delaware Assistant Professor Catherine Fromen and current graduate student Dominic Hoffman work with an adaptable lung model that can replicate realistic breathing maneuvers and offer ...

Cell and gene therapy tout promising results, but manufacturing challenges around personalized treatments require industry ...

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Technical leadership, predictive analytics, and personalized medicine can improve patient care. Here's what leaders in ...